Veritas Pharma Stock Market Value
| VRTHF Stock | USD 0 0.00 0.00% |
| Symbol | Veritas |
Veritas Pharma 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Veritas Pharma's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Veritas Pharma.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in Veritas Pharma on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding Veritas Pharma or generate 0.0% return on investment in Veritas Pharma over 30 days. Veritas Pharma is related to or competes with Medicine Man, Green Thumb, Earth Science, Ascend Wellness, Bionoid Pharma, and Centr Brands Corp. Indigenous Bloom Hemp Corp. focuses on the production of hemp products for commercial use More
Veritas Pharma Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Veritas Pharma's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Veritas Pharma upside and downside potential and time the market with a certain degree of confidence.
Veritas Pharma Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Veritas Pharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Veritas Pharma's standard deviation. In reality, there are many statistical measures that can use Veritas Pharma historical prices to predict the future Veritas Pharma's volatility.Veritas Pharma Backtested Returns
We have found three technical indicators for Veritas Pharma, which you can use to evaluate the volatility of the company. The entity has a beta of 0.0, which indicates not very significant fluctuations relative to the market. the returns on MARKET and Veritas Pharma are completely uncorrelated.
Auto-correlation | 1.00 |
Perfect predictability
Veritas Pharma has perfect predictability. Overlapping area represents the amount of predictability between Veritas Pharma time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Veritas Pharma price movement. The serial correlation of 1.0 indicates that 100.0% of current Veritas Pharma price fluctuation can be explain by its past prices.
| Correlation Coefficient | 1.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Veritas Pharma lagged returns against current returns
Autocorrelation, which is Veritas Pharma pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Veritas Pharma's pink sheet expected returns. We can calculate the autocorrelation of Veritas Pharma returns to help us make a trade decision. For example, suppose you find that Veritas Pharma has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Veritas Pharma regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Veritas Pharma pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Veritas Pharma pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Veritas Pharma pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Veritas Pharma Lagged Returns
When evaluating Veritas Pharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Veritas Pharma pink sheet have on its future price. Veritas Pharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Veritas Pharma autocorrelation shows the relationship between Veritas Pharma pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Veritas Pharma.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Veritas Pink Sheet
Veritas Pharma financial ratios help investors to determine whether Veritas Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Veritas with respect to the benefits of owning Veritas Pharma security.